Viewing Study NCT02958358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-02-27 @ 10:39 AM
Study NCT ID: NCT02958358
Status: WITHDRAWN
Last Update Posted: 2016-11-15
First Post: 2015-04-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan
Sponsor: Robert Scott Harris, M.D.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pulmonary Arterial Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pulmonary hypertension View
None ambrisentan View
None PET imaging View
None CT/PET View